Welcome to our dedicated page for Paychex SEC filings (Ticker: PAYX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Paychex, Inc. (Nasdaq: PAYX) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, drawn from the U.S. Securities and Exchange Commission’s EDGAR system. As a Delaware corporation with shares listed on the Nasdaq Global Select Market, Paychex files a range of documents that give investors and analysts detailed insight into its human capital management (HCM) and payroll services business.
Among the most important filings for PAYX are its annual reports on Form 10-K and quarterly reports on Form 10-Q, which include audited or reviewed financial statements, segment information, discussion of operations, risk factors, and management’s analysis of results. These filings are central for understanding how Paychex generates revenue from cloud-based payroll and HCM software, administrative service organization and professional employer organization offerings, and retirement and insurance-related services, as described in company materials.
Investors will also find current reports on Form 8-K, which Paychex uses to furnish earnings press releases, report on significant corporate events, and provide information about transactions. Recent 8-K filings referenced in the data include results of operations for specific quarters, details of the Paycor HCM, Inc. acquisition, annual meeting voting outcomes, and changes in senior leadership roles.
The definitive proxy statement on Schedule 14A offers additional detail on corporate governance, director elections, executive compensation, and shareholder voting matters. This document can be useful for evaluating Paychex’s governance structure, compensation policies, and shareholder engagement practices.
On Stock Titan, these PAYX filings are updated in near real time as they are posted to EDGAR. AI-powered tools can help summarize lengthy documents such as 10-Ks and 10-Qs, highlight key metrics and disclosures, and surface notable items from 8-Ks, proxy materials, and other submissions. Users researching Paychex’s financial performance, acquisition activity, compensation programs, or governance can use this page as a centralized entry point to the company’s regulatory record, including any insider transaction reports (Form 4) and other relevant SEC forms as they become available.
Capital International Investors reports beneficial ownership of 23,108,013 shares of Paychex, Inc. common stock, representing 6.4% of the 360,190,668 shares the filing states are outstanding. The filer, organized in Delaware, is identified as an investment adviser (type IA) and says it has sole voting power over 22,758,850 shares and sole dispositive power over 23,108,013 shares, with no shared voting or dispositive power. The filing states these securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Paychex, Inc. (PAYX) – Form 144 notice of proposed sale
The filing discloses that an affiliate intends to sell up to 21,642 common shares of Paychex through Merrill Lynch (9128 Strada Pl, Naples FL) on or after 14 July 2025. Based on the stated aggregate market value of $3,114,070.73, the planned sale represents roughly 0.006 % of the 360,190,668 shares outstanding—an immaterial proportion of the float. The shares were originally gifted by Martin Mucci on 11 July 2025, reflecting underlying donations made between 2007 and 2013. No other Paychex shares have been sold by this filer in the past three months, and the signer affirms no knowledge of undisclosed adverse information.
Rule 144 filings are routine compliance documents that allow insiders or affiliates to sell restricted or control stock, provided they meet volume, timing and manner-of-sale conditions. Given the modest transaction size relative to Paychex’s market capitalization, the notice is unlikely to exert meaningful pressure on the share price or alter the company’s fundamental outlook.